Bullfrog AI appoints Dr. Gwenn Smith and Dr. Jeremiah Wala as scientific advisors

BullFrog AI Holdings, Inc.

Dr. Gwenn Smith (Johns Hopkins) adds expertise in brain imaging, neuropsychiatry, and Alzheimer's disease.
Dr. Jeremiah Wala (Dana-Farber) brings computational biology and oncology focus on structural variation in cancer genomes.
Advisors will support Bullfrog AI's AI-driven drug development platform bfLEAP and its partnership with Lieber Institute.
Appointments effective January 26, 2024; both will guide the company's mission to develop breakthrough therapies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.